Volume 4, Pages 193-197 (September 2014) Elevated urinary albumin excretion complements the Framingham Risk Score for the prediction of cardiovascular risk — response to treatment in the PREVEND IT trial Frank P. Brouwers, Folkert W. Asselbergs, Hans L. Hillege, Ron T. Gansevoort, Rudolf A. de Boer, Wiek H. van Gilst IJC Heart & Vessels Volume 4, Pages 193-197 (September 2014) DOI: 10.1016/j.ijchv.2014.04.004 Copyright © 2014 Terms and Conditions
Fig. 1 Median urinary albumin excretion (mg/24 h) by treatment and visit. Triangles refer to placebo group and circles refer to treatment group (fosinopril). IJC Heart & Vessels 2014 4, 193-197DOI: (10.1016/j.ijchv.2014.04.004) Copyright © 2014 Terms and Conditions
Fig. 2 A and B. Predicted Framingham Risk Score compared to Kaplan–Meier estimates of incidence of cardiovascular events in fosinopril and placebo group, divided by a UAE < 50 mg/24 h and UAE ≥ 50 mg/24 h. IJC Heart & Vessels 2014 4, 193-197DOI: (10.1016/j.ijchv.2014.04.004) Copyright © 2014 Terms and Conditions